Arch Therapeutics Archives - Framingham SOURCE

Framingham Company Receives Approval Wound-Care Product in Europe

The following is a press release FRAMINGHAM- Arch Therapeutics, Inc., a developer of novel liquid, gel and solid hemostatic and